Good Distribution Practices

The distribution and transport of medicines and active ingredients (APIs) are key activities in the supply chain

The Pharmaceutical Industry, as well as regulatory agencies, are increasing efforts to ensure that active substances and medicines are properly managed throughout the supply chain

Distribution Practices

Globalization and offshoring of the pharmaceutical industry means that the supply chain for medicines and active ingredients is increasingly complex and involves a greater number of agents

In this environment, the distribution and transport of medicines and active ingredients (APIs) for human use are key supply chain activities that must be controlled in order to maintain the quality and integrity of the medicines, as set forth in the European regulations, 2011/62/EU and related Guides 2013/C 343/01 and 2015/C 95/01, as well as current FDA initiatives and expectations.

Control of the Supply Chain

Rephine’s wide experience working both with pharmaceutical laboratories and directly with the main actors involved in the supply chain, allows us to address different risk management strategies and to easily respond to issues.

Characterisation of the Supply Chain

How to identify all the actors involved in the supply chain?

What controls should be established along the supply chain?

Identification of the Agents

Who should have a GDP certificate for the distribution or transport of medicines?

What is a GDP certificate and who can issue it?

Definition of Responsibilities

How responsibilities along the supply chain should be defined?

Good Distribution Practices Services

Advice and compliance with GDP for distributors and transporters
Optimization of the supply chain and improvement of control in the supply chain through a risk management approach
Preparation of regulatory inspections, for the authorization of facilities
Qualification of facilities and warehouse utilities
Advise and preparation of the Quality System for logistics and distribution operations.

The distribution and transport of medicines and active ingredients (APIs) are key activities in the supply chain.

Project Compliance Lifecycle

Where do you Need our Help?

For GMP Auditing, Quality Assurance & Digitalisation, we’re the partner of choice for all the stakeholders we deal with.

We provide extensive GMP consulting services to help keep our clients ahead of the needs and expectations of regulators.

Global Audit Library

Explore our extensive GMP audit library to see the range and scope of live reports we have in stock, join a live audit, or commission a bespoke audit

GMP Audit Services

Maintain high standards of life sciences manufacturing supplier qualifications and GMP auditing within the supply chain through our expertise

GxP Consultancy

Discover how we can help your product reach to market, fully and demonstrably complying with the latest GxP standards

Digitalisation

From data integrity to implementing new systems, our experienced team with a digital mindset, can lead you to transformative achievements

Related Resources

Pharma equipment qualification hero image

Blog

Pharmaceutical Equipment Requalification: Policy, Risk Assessment & Best Practices

Struggling with requalification across complex pharma systems? Learn how expert-led policies and risk assessments can streamline your compliance strategy.

Blog

Risk-Based Auditing: Smarter GxP Compliance with Limited Resources

In today’s pharma landscape, risk-based auditing enables smarter supplier oversight by aligning audit efforts with risk. Discover the benefits, regulatory backing, and how Rephine helps ...

Case Study

Pharmaceutical Equipment Requalification Case Study

See how Rephine helped a global pharma company streamline equipment requalification across complex sites with a scalable, risk-based approach aligned with Annex 15.

Blog

Continuous Inspection Readiness Beyond Mock Audits

Traditional mock audits aren’t enough. With rising unannounced inspections, pharmaceutical and biotech firms must embrace continuous inspection readiness. This article explores how to embed compliance ...

Blog

How Rephine Accelerates Digital QMS Transformation in Pharma

Rephine helps pharmaceutical and biotech companies transition to digital QMS platforms like Veeva Vault, MasterControl, or TrackWise. From vendor-neutral selection to full GxP-compliant validation and ...

Blog

Threat Modelling in Medical Devices: STRIDE for MDR/IVDR Cybersecurity Compliance

Understand how STRIDE and other threat modelling techniques help medical device manufacturers meet MDR/IVDR cybersecurity requirements—plus real-world examples and expert insights.

Guide

Security Risk Management for Medical Devices: MDR & IVDR Compliance Whitepaper

Understand how to embed cybersecurity into the medical device lifecycle with this expert guide from Rephine. Includes MDR/IVDR, FDA, and IMDRF guidance on SRM, threat ...

Case Study

Pharmaceutical Equipment Qualification Case Study

See how Rephine helped a global pharmaceutical manufacturer accelerate equipment qualification using a GMP-aligned, risk-based strategy—saving time and improving compliance.

Blog

Equipment Qualification in the Pharmaceutical Industry: Lifecycle, Best Practices & Risk-Based Tips

Discover how to streamline equipment qualification in the pharmaceutical industry using a risk-based approach, modular documentation, and smart validation strategies. Learn practical tips to reduce ...

Let's get in touch

Please get in touch. Our expert GMP audit team is only a click away, on standby to answer all your questions.

Email: [email protected]

Social:

REPHINE HQ

Stevenage, UK
+44 1763 853135

REPHINE BARCELONA S.L.U

Barcelona, Spain
+34 934 178065

REPHINE CHINA

Shanghai, China

REPHINE INDIA

Hyderabad, India

First Name

Last Name

Phone

Country

Company

Job Title

Interested In

Message

Marketing Opt In

Rephine respects your privacy. Choosing to check the box means that you agree to the Rephine Privacy Policy. You can unsubscribe at any time.